1.Tourett's disorder and histocompatibility antigen.
Helen LEE ; Min Sook PARK ; Sing Kil MIN
Journal of Korean Neuropsychiatric Association 1991;30(3):500-506
No abstract available.
Histocompatibility Antigens*
;
Histocompatibility*
2.Histocompatibility antigens in primary gastric carcinoma of young adults.
Suk Joo LEE ; Wan Sik YOO ; Soo Il CHANG ; Yong Hwan CHOI ; Young Chul KIM ; Tae Ho JUNG
Journal of the Korean Cancer Association 1993;25(6):826-836
No abstract available.
Histocompatibility Antigens*
;
Histocompatibility*
;
Humans
;
Young Adult*
3.Selection of Thymocytes Expressing Transgenic TCR Specific for a Minor Histocompatibility Antigen, H60.
Ji Min JU ; Min Bum KIM ; Su Jeong RYU ; Joo Young KIM ; Jun CHANG ; Eun Young CHOI
Immune Network 2015;15(5):222-231
Minor histocompatibility antigens are MHC-bound peptides and contribute to the generation of allo-responses after allogeneic transplantation. H60 is a dominant minor H antigen that induces a strong CD8 T-cell response in MHC-matched allogeneic transplantation settings. Here, we report establishment of a TCR transgenic mouse line named J15, wherein T cells express TCRs specific for H60 in complex with H-2K(b), and different fates of the thymocytes expressing J15 TCRs in various thymic antigenic environments. Thymocytes expressing the J15 TCRs were positively selected and differentiated into CD8+ single positive (SP) cells in the thymus of C57BL/6 mice, wherein the cognate antigen H60 is not expressed. However, thymocytes were negatively selected in thymus tissue where H60 was transgenically expressed under the control of the actin promoter, with double-positive stages of cells being deleted. Despite the ability of the H60H peptide (LTFHYRNL) variant to induce cytotoxic activity from H60-specific CTL lines at ~50% of the activity induced by normal H60 peptides (LTFNYRNL), J15-expressing thymocytes were positively selected in the thymus where the variant H60H was transgenically expressed. These results demonstrate that a single amino-acid change in the H60 epitope peptide influences the fate of thymocytes expressing the cognate TCR.
Actins
;
Animals
;
Histocompatibility Antigens*
;
Histocompatibility*
;
Mice
;
Mice, Transgenic
;
Minor Histocompatibility Antigens
;
Peptides
;
T-Lymphocytes
;
Thymocytes*
;
Thymus Gland
;
Transplantation, Homologous
4.Characterization of CTL Clones Specific for Single Antigen, H60 Minor Histocompatibility Antigen.
Ji Yeong JEON ; Kyung Min JUNG ; Jun CHANG ; Eun Young CHOI
Immune Network 2011;11(2):100-106
BACKGROUND: Disparities of Minor H antigens can induce graft rejection after MHC-matched transplantation. H60 has been characterized as a dominant antigen expressed on hematopoietic cells and considered to be an ideal model antigen for study on graft-versus-leukemia effect. METHODS: Splenocytes from C57BL/6 mice immunized with H60 congenic splenocytes were used for establishment of H60-specific CTL clones. Then the clones were characterized for proliferation capacity and cytotoxicity after stimulation with H60. Clone #14, #15, and #23 were tested for the TCR binding avidity to H60-peptide/H-2Kb and analyzed for TCR sequences. RESULTS: H60-specific CTL clones showed different levels of proliferation capacity and cytotoxic activity to H60-stimulation. Clones #14, #15, and #23 showed high proliferation activity, high cytotoxicity, and low activities on both aspects, respectively, and have TCRs with different binding avidities to H60-peptide/H-2Kb with t 1/2 values of 4.87, 6.92, and 13.03 minutes, respectively. The TCR usages were Valpha12D-3-01+Jalpha11-01 and Vbeta12-1-01+Dbeta1-01+J2-7-01 for clone #14, Valpha13D-1-02+Jalpha34-02 and Vbeta13-1-02+Dbeta2-01+Jbeta2-7-01 for clone #15, and Valpha16D+Jalpha45-01 and Vbeta12-1-01+Dbeta1-01+Jbeta2-5-01 for clone #23. CONCLUSION: The results will be useful for modeling GVL and generation TCR transgenic mouse.
Animals
;
Clone Cells
;
Graft Rejection
;
Histocompatibility
;
Histocompatibility Antigens
;
Mice
;
Mice, Transgenic
;
Transplants
5.Ambiguous allele combinations in the HLA high resolution genotyping--review.
Journal of Experimental Hematology 2010;18(5):1345-1349
Human lymphocyte antigen (HLA) is the most complicated human dominant polymorphic genetic system. Accurate HLA genotyping is clinically important for hematopoietic stem cell (HSC) transplantation, also important for research on many human diseases. Polymerase chain reaction-sequence based typing (PCR-SBT) provides the highest resolution level and defines new alleles, so it is widely used for HLA typing. One great disadvantage of PCR-SBT method is the fact that it cannot resolve sequences of heterozygous samples in diploid genomes, leading to ambiguous typing results which make much trouble to the accurate definition of HLA genotype. This article reviewed the occurring reasons and solution method of ambiguous allele combinations in the HLA high resolution genotyping as well as the research prospect in this field.
Genotype
;
HLA Antigens
;
genetics
;
immunology
;
Histocompatibility Testing
;
Humans
7.Analysis of loss of heterozygosity at HLA loci in a patient with leukemia.
Wei WANG ; Fang WANG ; Lina DONG ; Nanying CHEN ; Yizhen HE ; Wei ZHANG ; Ji HE ; Faming ZHU
Chinese Journal of Medical Genetics 2022;39(3):338-342
OBJECTIVE:
To detect loss of heterozygosity (LOH) at human leukocyte antigen (HLA) loci in a Chinese patient with leukemia after haploidentical hematopoietic stem cell transplantation.
METHODS:
HLA genotyping was carried out on peripheral blood, hair follicle and buccal swab samples derived from the patient after the transplantation as well as peripheral blood samples from his parents by using PCR-sequence specific oligonucleotide probe method and PCR-sequence based typing method. Short tandem repeat (STR) loci were detected by using a 23 site STR assay kit and a self-developed 6 STR loci assay for the HLA regions.
RESULTS:
After the transplantation, the HLA genotype of the peripheral blood sample of the patient was identical to his father. The patient was HLA-A*02:01,24:02, C*03:03,03:04, B*13:01,15:01, DRB1*08:03,12:02, DQB1*03:01,06:01 for his hair follicle specimen. However, homozygosity of the HLA loci was found in his buccal swab sample. Only the HLA-A*24:02-C*03:03-B*15:01-DRB1*08:03-DQB1*06:01 haplotype from his father's was present, while the HLA-A*02:01-C*03:04-B*13:01-DRB1*12:02-DQB1*03:01 haplotype from his mother was lost. After the transplantation, the alleles of the 23 STR sites in the patient's peripheral blood sample were consistent to his father, with no allelic loss detected in his buccal swab sample. However, at least 4 STR loci in the HLA region were lost in his buccal swab sample.
CONCLUSION
LOH at the HLA loci has been detected in the buccal swab sample of a patient with leukemia who received haploidentical hematopoietic stem cell transplantation.
HLA Antigens/genetics*
;
HLA-A Antigens/genetics*
;
Histocompatibility Antigens Class I/genetics*
;
Humans
;
Leukemia/genetics*
;
Loss of Heterozygosity
8.Relationship between IgA nephropathy and Histocompatibility Antigens (HLA) in Korean Population.
Young Shin SHIN ; Young Ok KIM ; Chul Whee PARK ; Sung No YOON ; Chul Woo YANG ; Yong Soo KIM ; Yoon Sik CHANG ; Hoon HAN ; Byung Kee BANG
Korean Journal of Medicine 1998;54(2):217-226
OBJECTIVES: Primary IgA nephropathy(IgAN), currently recognized as the most prevalent form of glomerular disease in the world, has tendency toward end stage renal failure at a rate of 20-30% in patients after a long-term follow-up of more than 20 years. But its etiology and pathophysiology is not fully understood. This study was designed to evaluate the pattern of histocompatibility antigens(HLA) and its association with poor prognostic factors in patients with IgAN. METHODS: Study population comprised the 69 patients with IgAN which was diagnosed by clinical and pathological findings, and control groups were 202 healthy Korean people. We evaluated the HLA class I serologic typing by standard microlymphocytotoxic technique and the HLA class II genotypes by the two-step polymerase chain reaction. RESULTS: 1. HLA-A was not associated with IgAN. 2. The phenotype frequency of HLA-B55 was 6.1% in patient group and 1.7% in normal control group. HLAB55 was associated with IgAN(relative risk 3.47, P<0.05). 3. HLA-DQB1*04 was also associated with IgAN (relative risk 3.57, P<0.05). 4. There was no significant difference in the distribution of HLA in IgAN patients according to histologic grading, blood pressure, renal function and proteinuria. CONCLUSIONS: Frequencies of HLA-B55, HLA-DQB1 *04 are higher in Korean patients with IgAN compared to general population. But we could not observe the significant relationships between HLA type and poor prognostic factors. Further study using larger population with IgAN may be necessary to identify the association of HLA locus with poor prognostic factors and progress decline in renal function in patients with IgAN.
Blood Pressure
;
Genotype
;
Glomerulonephritis, IGA*
;
Histocompatibility Antigens*
;
Histocompatibility*
;
HLA-A Antigens
;
Humans
;
Immunoglobulin A*
;
Phenotype
;
Polymerase Chain Reaction
;
Proteinuria
;
Renal Insufficiency
9.Expression of major histocompatibility complex antigen in Lewis rat cornea.
Korean Journal of Ophthalmology 1994;8(2):66-71
Fresh rat corneas as well as corneas preserved in several different corneal preservation media were stained with Avidin-Biotin-peroxidase Complex method in order to evaluate major histocompatibility complex (MHC) antigen expression. In fresh corneas, class I antigen was identified in corneal epithelium, stroma and endothelium. Class II antigen was identified only in stroma. In corneas preserved in the media which contained chondroitin and dextran for 7 days, class I antigen was somewhat decreased but class II antigen was increased. In corneas preserved in the medium which contained insulin or epidermal growth factor for 7 days, class II antigens seemed to be increased compaired to the fresh cornea. Expression of MHC antigens of corneas in the medium with fetal bovine serum were similar to those of fresh corneas.
Animals
;
Cornea/*metabolism
;
Culture Media
;
Histocompatibility Antigens Class I/*biosynthesis
;
Histocompatibility Antigens Class II/*biosynthesis
;
Immunoenzyme Techniques
;
Major Histocompatibility Complex
;
Organ Preservation/methods
;
Rats
;
Rats, Inbred Lew
10.HLA Typing Proficiency Survey in Korea, 2003-2004.
Ji Hun LIM ; Sang Hyun HWANG ; Heung Bum OH
The Korean Journal of Laboratory Medicine 2005;25(6):434-441
BACKGROUND: HLA proficiency survey in Korea started in 1996 and the results of the survey were last reported in 1999. In this report, we summarized the results of the survey performed in recent 2 years. METHODS: A total of four proficiency surveys were performed, in which 54-59 laboratories participated. Each survey included 3 tests for HLA class I (serology and DNA) and class II (DNA) typing and 6 for HLA crossmatch test (3 cells x 2 sera). RESULTS: Overall concordance of serologic typing was 99.5% (436/438) for HLA-A, 95.7% (419/438) for HLA-B, and 94.8% (199/210) for HLA-C. The antigens assigned incorrectly by more than 5% of the participating laboratories were B54 (10.3%), B55 (10.3%), B27 (5.4%), Cw6 (22.9%), and C-blank (5.7%). Overall concordance rates of DNA typing were 99.7% (393/394) for HLA-A, 99.8% (415/416) for HLA-B, 100% (156/156) for HLA-C. Correct assignment of HLA-DRB1 and -DQB1 was reportred by 99.7% (98.1-100%) and 99.2% (88.9-100%) for generic and 99.2% and 98.1% (80-100%) for allelic level, respectively. Most laboratories (93.5-97.9%) were using sensitive methods of crossmatch such as T-long, T-AHG, and flowcytometry. The proportion of laboratories evaluated as unacceptable was on the average 3.1% of total laboratories. CONCLUSIONS: The rate of correct identification of HLA antigens was higher this time than in the previous survey in 1999. The rate of unacceptable crossmatch was also low enough to be satisfactory. It is thought that the proficiency survey has contributed to the high quality of HLA tests in the participating laboratories and should be continued to maintain the proficiency in Korea.
DNA Fingerprinting
;
Histocompatibility Testing*
;
HLA Antigens
;
HLA-A Antigens
;
HLA-B Antigens
;
HLA-C Antigens
;
HLA-DRB1 Chains
;
Korea